Bank of New York Mellon’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.97B | Buy |
3,938,410
+171,796
| +5% | +$82.5M | 0.32% | 50 |
|
|
2026
Q1 | $1.85B | Buy |
3,766,614
+42,138
| +1% | +$22.9M | 0.34% | 50 |
|
|
2025
Q4 | $2.16B | Buy |
3,724,476
+152,619
| +4% | +$86.3M | 0.38% | 42 |
|
|
2025
Q3 | $1.73B | Buy |
3,571,857
+1,262,967
| +55% | +$588M | 0.31% | 52 |
|
|
2025
Q2 | $936M | Sell |
2,308,890
-220,106
| -9% | -$92M | 0.18% | 110 |
|
|
2025
Q1 | $1.26B | Sell |
2,528,996
-28,201
| -1% | -$15.3M | 0.25% | 76 |
|
|
2024
Q4 | $1.33B | Sell |
2,557,197
-71,192
| -3% | -$39.1M | 0.25% | 74 |
|
|
2024
Q3 | $1.63B | Sell |
2,628,389
-68,669
| -3% | -$40.6M | 0.3% | 57 |
|
|
2024
Q2 | $1.49B | Sell |
2,697,058
-102,818
| -4% | -$58.9M | 0.28% | 64 |
|
|
2024
Q1 | $1.63B | Sell |
2,799,876
-159,524
| -5% | -$89.5M | 0.31% | 65 |
|
|
2023
Q4 | $1.57B | Sell |
2,959,400
-135,700
| -4% | -$65.7M | 0.32% | 60 |
|
|
2023
Q3 | $1.57B | Sell |
3,095,100
-102,419
| -3% | -$54.6M | 0.34% | 50 |
|
|
2023
Q2 | $1.67B | Sell |
3,197,519
-150,520
| -4% | -$81.2M | 0.35% | 52 |
|
|
2023
Q1 | $1.93B | Sell |
3,348,039
-72,686
| -2% | -$41M | 0.42% | 40 |
|
|
2022
Q4 | $1.88B | Buy |
3,420,725
+54,075
| +2% | +$28.7M | 0.43% | 42 |
|
|
2022
Q3 | $1.71B | Sell |
3,366,650
-62,606
| -2% | -$35M | 0.41% | 43 |
|
|
2022
Q2 | $1.86B | Buy |
3,429,256
+16,865
| +0.5% | +$9.28M | 0.43% | 42 |
|
|
2022
Q1 | $2.02B | Sell |
3,412,391
-452,163
| -12% | -$260M | 0.39% | 46 |
|
|
2021
Q4 | $2.58B | Sell |
3,864,554
-87,489
| -2% | -$54.6M | 0.47% | 37 |
|
|
2021
Q3 | $2.26B | Sell |
3,952,043
-41,545
| -1% | -$22.8M | 0.44% | 41 |
|
|
2021
Q2 | $2.01B | Buy |
3,993,588
+381,863
| +11% | +$180M | 0.39% | 50 |
|
|
2021
Q1 | $1.65B | Buy |
3,611,725
+63,408
| +2% | +$30.3M | 0.34% | 61 |
|
|
2020
Q4 | $1.65B | Sell |
3,548,317
-114,517
| -3% | -$53.7M | 0.36% | 57 |
|
|
2020
Q3 | $1.62B | Buy |
3,662,834
+193,462
| +6% | +$79.9M | 0.4% | 53 |
|
|
2020
Q2 | $1.26B | Buy |
3,469,372
+22,856
| +0.7% | +$7.66M | 0.34% | 65 |
|
|
2020
Q1 | $977M | Sell |
3,446,516
-100,382
| -3% | -$31.7M | 0.32% | 66 |
|
|
2019
Q4 | $1.15B | Sell |
3,546,898
-48,998
| -1% | -$14.9M | 0.3% | 74 |
|
|
2019
Q3 | $1.05B | Buy |
3,595,896
+36,229
| +1% | +$10.4M | 0.29% | 70 |
|
|
2019
Q2 | $1.05B | Buy |
3,559,667
+102,504
| +3% | +$28.2M | 0.29% | 70 |
|
|
2019
Q1 | $946M | Buy |
3,457,163
+259,622
| +8% | +$64.6M | 0.26% | 75 |
|
|
2018
Q4 | $716M | Sell |
3,197,541
-99,202
| -3% | -$23.3M | 0.22% | 87 |
|
|
2018
Q3 | $805M | Sell |
3,296,743
-8,603
| -0.3% | -$1.98M | 0.21% | 89 |
|
|
2018
Q2 | $685M | Sell |
3,305,346
-75,767
| -2% | -$16.1M | 0.19% | 103 |
|
|
2018
Q1 | $698M | Sell |
3,381,113
-116,875
| -3% | -$24.5M | 0.19% | 99 |
|
|
2017
Q4 | $664M | Sell |
3,497,988
-18,931
| -0.5% | -$3.63M | 0.17% | 113 |
|
|
2017
Q3 | $665M | Sell |
3,516,919
-30,079
| -0.8% | -$5.45M | 0.18% | 106 |
|
|
2017
Q2 | $619M | Sell |
3,546,998
-265,208
| -7% | -$44.5M | 0.17% | 114 |
|
|
2017
Q1 | $586M | Sell |
3,812,206
-69,732
| -2% | -$10.7M | 0.16% | 122 |
|
|
2016
Q4 | $548M | Sell |
3,881,938
-122,955
| -3% | -$18.1M | 0.16% | 130 |
|
|
2016
Q3 | $637M | Buy |
4,004,893
+254,995
| +7% | +$39.3M | 0.19% | 106 |
|
|
2016
Q2 | $554M | Sell |
3,749,898
-66,248
| -2% | -$9.78M | 0.17% | 126 |
|
|
2016
Q1 | $540M | Sell |
3,816,146
-181,298
| -5% | -$24.3M | 0.16% | 130 |
|
|
2015
Q4 | $567M | Sell |
3,997,444
-153,024
| -4% | -$20.4M | 0.17% | 123 |
|
|
2015
Q3 | $508M | Sell |
4,150,468
-112,506
| -3% | -$14.7M | 0.16% | 132 |
|
|
2015
Q2 | $553M | Sell |
4,262,974
-270,000
| -6% | -$35.2M | 0.15% | 135 |
|
|
2015
Q1 | $609M | Sell |
4,532,974
-580,004
| -11% | -$74.8M | 0.16% | 132 |
|
|
2014
Q4 | $641M | Buy |
5,112,978
+22,566
| +0.4% | +$2.74M | 0.17% | 126 |
|
|
2014
Q3 | $620M | Sell |
5,090,412
-35,269
| -0.7% | -$4.29M | 0.17% | 126 |
|
|
2014
Q2 | $605M | Buy |
5,125,681
+2,668
| +0.1% | +$314K | 0.16% | 128 |
|
|
2014
Q1 | $616M | Buy |
5,123,013
+474,328
| +10% | +$56.4M | 0.17% | 120 |
|
|
2013
Q4 | $518M | Sell |
4,648,685
-920,628
| -17% | -$91.5M | 0.14% | 146 |
|
|
2013
Q3 | $513M | Sell |
5,569,313
-82,008
| -1% | -$7.42M | 0.15% | 134 |
|
|
2013
Q2 | $478M | Buy |
+5,651,321
| New | +$470M | 0.15% | 129 |
|
Other funds holding TMO
N
Bank of New York Mellon's TMO Position: Q2 2026 in Review
Bank of New York Mellon increased its Thermo Fisher Scientific (TMO) stake by 4.6% in Q2 2026, buying an estimated $82.5M and bringing the position to 3,938,410 shares worth $1.97B. The position accounts for 0.32% of the portfolio, ranked #50.
Bank of New York Mellon first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.58B in Q4 2021. 1,883 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Bank of New York Mellon held 3,938,410 shares of Thermo Fisher Scientific worth $1.97B as of Q2 2026.
- Bank of New York Mellon bought 171,796 Thermo Fisher Scientific shares in Q2 2026, an estimated $82.5M.
- Thermo Fisher Scientific made up 0.32% of Bank of New York Mellon's portfolio in Q2 2026, its #50 holding.
- Bank of New York Mellon first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Thermo Fisher Scientific position peaked at $2.58B in Q4 2021.
- 1,883 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.